Business · 28/12/2023Updated: 10/17/2026 · 1 min read
FDA Issues Guidance for Reformulating Drug Products Containing Benzene-Contaminated Carbomers
Summary
The FDA has released a final guidance to help pharmaceutical companies reformulate their products that contain carbomers manufactured with benzene, a contaminant that poses safety concerns.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →